Preferred Name | Mesalamine | |
Synonyms |
5-Aminosalicylate Pentasa Monosodium Salt, Mesalamine Novo 5 ASA 5 Aminosalicylate Mesalamine Hydrochloride Claversal Ascolitin Asacolon m-Aminosalicylic Acid Fivasa Mesalamine Monosodium Salt Lixacol 5-Aminosalicylic Acid Mesalazine meta Aminosalicylic Acid 5 Aminosalicylic Acid meta-Aminosalicylic Acid Canasa Rowasa Novo-5 ASA Salofalk Asacol Hydrochloride, Mesalamine m Aminosalicylic Acid Mesasal |
|
Definitions |
An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed) |
|
ID |
http://purl.bioontology.org/ontology/MESH/D019804 |
|
altLabel |
5-Aminosalicylate Pentasa Monosodium Salt, Mesalamine Novo 5 ASA 5 Aminosalicylate Mesalamine Hydrochloride Claversal Ascolitin Asacolon m-Aminosalicylic Acid Fivasa Mesalamine Monosodium Salt Lixacol 5-Aminosalicylic Acid Mesalazine meta Aminosalicylic Acid 5 Aminosalicylic Acid meta-Aminosalicylic Acid Canasa Rowasa Novo-5 ASA Salofalk Asacol Hydrochloride, Mesalamine m Aminosalicylic Acid Mesasal |
|
AQL |
AD AE AG AI AN BL CF CH CL CS EC HI IM IP ME PD PK PO RE SD ST TO TU UR |
|
cui |
C1563970 C0886581 C0678172 C0699622 C0886582 C0678169 C4083158 C0678171 C1563971 C1563969 C0127615 C0699623 C0699621 C1563973 C1563972 C0098148 |
|
DC |
1 |
|
definition |
An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed) |
|
DX |
19980101 |
|
EC |
analogs & derivatives:Aminosalicylic Acids |
|
HN |
98; use MESALAMINE (NM) 1981-97 |
|
Inverse of AQ |
http://purl.bioontology.org/ontology/MESH/Q000097 http://purl.bioontology.org/ontology/MESH/Q000627 http://purl.bioontology.org/ontology/MESH/Q000493 http://purl.bioontology.org/ontology/MESH/Q000494 http://purl.bioontology.org/ontology/MESH/Q000276 http://purl.bioontology.org/ontology/MESH/Q000138 http://purl.bioontology.org/ontology/MESH/Q000134 http://purl.bioontology.org/ontology/MESH/Q000266 http://purl.bioontology.org/ontology/MESH/Q000378 http://purl.bioontology.org/ontology/MESH/Q000008 http://purl.bioontology.org/ontology/MESH/Q000009 http://purl.bioontology.org/ontology/MESH/Q000032 http://purl.bioontology.org/ontology/MESH/Q000037 http://purl.bioontology.org/ontology/MESH/Q000191 http://purl.bioontology.org/ontology/MESH/Q000302 http://purl.bioontology.org/ontology/MESH/Q000145 http://purl.bioontology.org/ontology/MESH/Q000592 http://purl.bioontology.org/ontology/MESH/Q000737 http://purl.bioontology.org/ontology/MESH/Q000819 http://purl.bioontology.org/ontology/MESH/Q000506 http://purl.bioontology.org/ontology/MESH/Q000633 http://purl.bioontology.org/ontology/MESH/Q000600 |
|
Inverse of RB |
6291-36-7 35589-28-7 0 4Q81I59GXC |
|
isa | ||
LT |
TRD |
|
Machine permutation |
98; MESALAMINE was indexed under AMINOSALICYLIC ACIDS 1981-97 |
|
Mapped from |
http://purl.bioontology.org/ontology/MESH/C038637 |
|
MDA |
19970620 |
|
MMR |
20170117 |
|
MN |
D02.455.426.559.389.127.281.595.100.540 D02.455.426.559.389.127.020.452.750 D02.241.511.390.595.100.540 D02.455.426.559.389.657.410.595.100.540 D02.241.223.100.050.300.500 D02.241.223.100.300.595.100.540 |
|
notation |
D019804 |
|
PA |
D000894 |
|
prefLabel |
Mesalamine |
|
RR |
35589-28-7 (mono-Na salt) 6291-36-7 (HCl) 89-57-6 (Mesalamine) |
|
TERMUI |
T616186 T058915 T058918 T058905 T058914 T058916 T058907 T058911 T359319 T616208 T359318 T616206 T058917 T616210 T058909 T616183 T058910 T616188 T058913 T058912 |
|
TH |
US MX UK NL NLM (1999) CA USAN (1986) FDA SRS (2014) ES INN (19XX) DE AU NLM (1998) USP (19XX) BAN (19XX) FR IE |
|
tui |
T109 T116 T129 T121 |
|
subClassOf |